| Asthma |
1 |
1 |
| Bronchiectasis |
0 |
0.99 |
| Inhaled Corticosteroid |
0 |
0.63 |
| Corticosteroids |
0 |
0.49 |
| Lung |
0 |
0.11 |
| Otolaryngology |
0 |
0.09 |
| Blood |
0 |
0.08 |
| Chronic Obstructive Pulmonary Disease |
0 |
0.08 |
| Pulmonary Function Test |
0 |
0.08 |
| Biologic Therapy |
0 |
0.05 |
| CT Scan |
0 |
0.05 |
| Eosinophils |
0 |
0.05 |
| Europe |
0 |
0.05 |
| Airway Inflammation |
0 |
0.04 |
| Dentistry and Oral Health |
0 |
0.04 |
| Fungal Infection |
0 |
0.04 |
| Heart Failure (HF) |
0 |
0.04 |
| Patient Safety |
0 |
0.04 |
| Pulmonary Arterial Hypertension |
0 |
0.04 |
| Adrenal Insufficiency |
0 |
0.03 |
| Adverse Effects |
0 |
0.03 |
| Airway |
0 |
0.03 |
| Allergy |
0 |
0.03 |
| Antibiotics |
0 |
0.03 |
| Body Mass Index |
0 |
0.03 |
| Bronchodilator |
0 |
0.03 |
| Candidiasis |
0 |
0.03 |
| Clinical Guidelines |
0 |
0.03 |
| Cystic Fibrosis |
0 |
0.03 |
| Dysphonia |
0 |
0.03 |
| Hospital |
0 |
0.03 |
| Hypertension |
0 |
0.03 |
| Immunocompromise |
0 |
0.03 |
| Immunology |
0 |
0.03 |
| Leukotrienes |
0 |
0.03 |
| Massachusetts |
0 |
0.03 |
| Oral Candidiasis |
0 |
0.03 |
| Pulmonary Hypertension |
0 |
0.03 |
| Quality of Life |
0 |
0.03 |
| Receptors |
0 |
0.03 |
| Steroids |
0 |
0.03 |
| Thorax |
0 |
0.03 |
| Tuberculosis |
0 |
0.03 |